Lantheus Holdings (LNTH) had its Relative Strength (RS) Rating upgraded from 80 to 83 Tuesday.
↑ XThis exclusive rating from Investor's Business Daily tracks share price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the best-performing stocks tend to have an 80 or higher RS Rating in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
While Lantheus Holdings is not near an ideal buy zone right now, see if it goes on to form and break out of a proper consolidation.
Lantheus Holdings showed 16% EPS growth in the latest quarterly report. Sales gains came in at 18%.
The company holds the No. 8 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), Pro-Dex (PDEX) and Insulet (PODD) are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。